← Open Payments lookup

GENESIS CABRERA: Open Payments

NPI 1255063343 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,792 in 117 payments from 14 companies in 2025. Trend: 2023 $3,690 · 2024 $1,779 · 2025 $2,792

Food & beverage: $2,705Education: $87
CompanyPaymentsAmount
GENZYME CORPORATION20$621
ABBVIE INC.22$405
Lilly USA, LLC14$346
LEO Pharma Inc.17$260
Incyte Corporation6$241
Arcutis Biotherapeutics, Inc.10$225
PFIZER INC.8$170
Janssen Biotech, Inc.7$169
Galderma Laboratories, L.P.5$117
SUN PHARMACEUTICAL INDUSTRIES INC.4$96

Products named: DUPIXENT, RINVOQ, OPZELURA, Zoryve, TALTZ, TREMFYA, ADBRY, SKYRIZI.

Industry payments across NY — which companies pay providers there.